Related Experiment Video
Updated: Nov 28, 2025

07:53
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
11.4K
Quercetin Covalently Linked Lipid Nanoparticles: Multifaceted Killing Effect on Tumor Cells
Shao-Qing Chen1, Cheng Wang1, Yan-Qing Song1
1College of Pharmaceutical Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou 310058, China.
ACS Omega
|November 30, 2020
Summary
Researchers developed novel lipid nanoparticles to deliver hydrophobic drugs, enhancing tumor cell killing through targeted quercetin release. This approach shows promise for overcoming drug resistance and improving cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery
Background:
- Hydrophobic drug encapsulation is a significant challenge in drug delivery.
- Developing effective nanoformulations is crucial for enhancing drug efficacy and overcoming resistance.
Purpose of the Study:
- To synthesize and characterize novel lipid nanoparticles (LNPs) for hydrophobic drug delivery.
- To investigate the tumor cell-killing mechanisms of these nanoformulations.
- To improve the delivery of hydrophobic drugs, specifically quercetin (Qu), for enhanced anti-cancer effects.
Main Methods:
- Covalent linkage of lipophilic quercetin (Qu) to glyceryl caprylate-caprate (Gcc) via disulfide bonds using 3,3'-dithiodipropionic acid (DTPA) to create Qu-SS-Gcc.
- Fabrication of Qu-SS-Gcc lipid nanoparticles (LNPs) using the solvent diffusion technique.
- Intracellular release studies using liquid chromatography, fluorescent quantitation, flow cytometry, and western blot to explore mechanisms in MCF-7/ADR cells.
Main Results:
- Qu-SS-Gcc LNPs effectively released Qu in MCF-7/ADR cells due to high concentrations of reduction molecules.
- Intracellular Qu levels were higher from Qu-SS-Gcc LNPs compared to free Qu.
- Qu-SS-Gcc LNPs demonstrated superior killing effects by inhibiting P-gp, arresting the cell cycle at G2, and inducing apoptosis and autophagy.
Conclusions:
- Qu-SS-Gcc LNPs facilitate massive accumulation of Qu in tumor cells, leading to multifaceted cell killing.
- The study provides a valuable reference for the delivery of hydrophobic drugs using prodrugs and nanoformulations.
- Autophagy's dual role as a survival or cell-killing mechanism depending on concentration was observed.
Related Concept Videos
Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K
Cancer Therapies
9.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.3K

